Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.
about
Thrombosis Associated with Viral HepatitisImmune thrombocytopeniaContemporary management of primary immune thrombocytopenia in adultsThe epidemiology of venous thromboembolismRisk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation.Diagnosis and management of maternal thrombocytopenia in pregnancy.Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopeniaThe biology of thrombopoietin and thrombopoietin receptor agonists.Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.Effect of steroids on the activation status of platelets in patients with Immune thrombocytopenia (ITP).The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.Thrombopoietin levels in systemic lupus erythematosus are linked to inflammatory cytokines, but unrelated to thrombocytopenia or thrombosis.Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.Thrombophilia in patients with chronic immune thrombocytopenia.Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System.Fatigue in immune thrombocytopenia.Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.Is ITP a thrombophilic disorder?Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies.Cytokine-induced killer cell therapy-associated idiopathic thrombocytopenic purpura: rare but noteworthy.Long-term results of splenectomy in adult chronic immune thrombocytopenia.Procoagulant profile in patients with immune thrombocytopenia.Long-term complications of splenectomy in adult immune thrombocytopenia.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Clinical updates in adult immune thrombocytopenia.Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases.Fibronectin maintains the balance between hemostasis and thrombosis.Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012.Epidemiology of venous thromboembolism.
P2860
Q26781784-FE4419C4-C5FE-4CEC-9531-9FA436F2F604Q26830918-8157B208-3FA4-4392-89CE-AE80E70F24CCQ26853680-B8A514BA-312D-4055-8542-FA35CC1653E0Q28067893-8DEA3CDD-A68B-4AB2-A8AF-0D9C7222AB4DQ30205757-9E50EF28-95F7-4A82-ACE6-70AB46B190AEQ30250259-3E50C665-5BF0-4137-99D5-772563E3C2E4Q30399669-62160FFF-C105-4974-AD97-A2342F2D524CQ33399437-2278B451-F145-4629-9A0F-7FDF060D2F67Q33401045-C6453E87-DA5F-42E1-8A69-3A4151F0AB05Q33404320-C5631381-75C7-4E84-82D5-94586D2F6E16Q33406643-BE72619F-E156-4DD6-9FB0-AE92CD06E6F7Q33406804-FCD5E932-D525-4299-B0C3-60F245EB5661Q33407110-2042FA07-AE50-462C-A0EE-1E9CFEB62BE0Q33407451-00C1FA2E-FC9F-48F1-8417-56304B97F183Q33408850-CD585F29-9D88-48A2-A027-69A76C6B391DQ33409611-3989099C-749E-441D-A872-577F233BA935Q33410348-0DFC13EF-6540-4D3F-A81E-42EC349F8D9CQ33413853-5392C913-C3D3-433F-9CBE-97CE38A8A126Q33414386-AC01CA25-3D8C-45CA-B46D-C46CD55920A1Q33415996-18EA319A-0363-4B9A-9115-E39C47E9ECDAQ33417017-DB2787A6-2764-4A0A-8C56-0616BFAB6C4DQ33417504-2560B3E0-0A9E-46A4-A737-8CCB4E43F837Q33418053-2210ECA1-708D-4628-BD78-B444FCC0D860Q33418453-4CF1A176-D062-4F5C-9A57-1D8D9BAEC37AQ33421555-3CDB9A07-B355-419E-B3F8-07A941A76F63Q33424664-3522C8E1-F963-47B3-A901-FD20F3DBB127Q33425644-0CBCD09A-F6A2-4D01-ADC3-4531CF68E240Q33427394-F07FD5D8-7DF6-455C-984A-25F41E7B9F19Q33428724-9DFEEDED-2124-4C7E-974E-4F4C03C4F20EQ33431551-352673BF-00CB-4E02-84C9-D60715AB1ECEQ33434310-A1BBB350-2378-4FAA-8DC9-4B12507CCDC9Q33436100-F262FC85-F65A-4AEB-BFC4-B2B6D2B0E86CQ33436189-77BE04C7-69C4-4F1E-AB67-7C29F5407546Q33437227-11A72610-65D1-43AB-BC1D-E354185DA7D6Q33439412-BD018C1C-18DC-4269-B344-F79C98B5B725Q33441061-A0CB8CE4-6480-4B1F-9E67-99714DB1A894Q35770811-36263357-E867-4FA8-84A2-4A3379A447B1Q38813246-8D6C2704-DAEB-446B-8B6E-99055B9E2EF5Q40176999-01E27B04-C54B-4DF6-8FBF-FA51DDC7DCC2Q41667853-2AE67F87-A28F-48BD-8F79-9A710C4BB018
P2860
Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Risk of venous thromboembolism ...... population-based cohort study.
@en
Risk of venous thromboembolism ...... population-based cohort study.
@nl
type
label
Risk of venous thromboembolism ...... population-based cohort study.
@en
Risk of venous thromboembolism ...... population-based cohort study.
@nl
prefLabel
Risk of venous thromboembolism ...... population-based cohort study.
@en
Risk of venous thromboembolism ...... population-based cohort study.
@nl
P2093
P2860
P50
P1476
Risk of venous thromboembolism ...... population-based cohort study.
@en
P2093
Annette Østergaard Jensen
Dora Körmendiné Farkas
Malene Cramer Engebjerg
P2860
P304
P356
10.1111/J.1365-2141.2010.08418.X
P407
P577
2010-10-19T00:00:00Z